NCT06291311Recruiting
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Treatment of Infections of the Cervix Uteri With High- and Low-risk Variants of the Human Papillomavirus Using Non-invasive Physical Plasma
Source: ClinicalTrials.gov · Last updated 30 Jun 2026
Brief summary (registry, in English)
This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 26 Feb 2024
- Start date
- 27 Dec 2023
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- University Hospital Tuebingen
- Diseases
- Cervical cancer
- NCT number
- NCT06291311
What you commit to
- Study type: Observational
- Planned participants: 50
- From 27 Dec 2023 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Evidence of invasive disease
- Serious cardiovascular diseases
Other
- The following exclusion criteria apply to both groups of patients (NIPP treatment and control group).
- Transformation zone not fully visible
Who the study is looking for
- Inclusion criteria for NIPP treatment
- Age ≥ 18 years
- mRNA or DNA-based virus detection by smear (also external findings)
- Clearly visible transformation zone of the cervix and margins of the lesions corresponding to T1/T2
- Written informed consent to participate in the study
- Inclusion criteria for control group
- Age ≥ 18 years
- Swab-based mRNA or DNA-based virus detection (also external findings)
- Clearly visible transformation zone of the cervix corresponding to T1/T2
- Written informed consent to participate in the study
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Tuebingen, Department of Women's Health Coordinator of this site? Confirm its status | Tübingen | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.